541 related articles for article (PubMed ID: 29557770)
1. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
Sisk JM; Frieman MB; Machamer CE
J Gen Virol; 2018 May; 99(5):619-630. PubMed ID: 29557770
[TBL] [Abstract][Full Text] [Related]
2. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
3. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
4. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation.
Qian Z; Dominguez SR; Holmes KV
PLoS One; 2013; 8(10):e76469. PubMed ID: 24098509
[TBL] [Abstract][Full Text] [Related]
5. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
6. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
7. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
8. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Yamamoto M; Matsuyama S; Li X; Takeda M; Kawaguchi Y; Inoue JI; Matsuda Z
Antimicrob Agents Chemother; 2016 Nov; 60(11):6532-6539. PubMed ID: 27550352
[TBL] [Abstract][Full Text] [Related]
9. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
10. [Development of peptidic MERS-CoV entry inhibitors].
Xia S; Wang Q; Liu SW; Lu L; Jiang SB
Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
[TBL] [Abstract][Full Text] [Related]
11. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
Earnest JT; Hantak MP; Li K; McCray PB; Perlman S; Gallagher T
PLoS Pathog; 2017 Jul; 13(7):e1006546. PubMed ID: 28759649
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism.
Park JE; Li K; Barlan A; Fehr AR; Perlman S; McCray PB; Gallagher T
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12262-12267. PubMed ID: 27791014
[TBL] [Abstract][Full Text] [Related]
13. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.
Qian Z; Ou X; Góes LG; Osborne C; Castano A; Holmes KV; Dominguez SR
J Virol; 2015 Sep; 89(17):8816-27. PubMed ID: 26085157
[TBL] [Abstract][Full Text] [Related]
15. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
[TBL] [Abstract][Full Text] [Related]
16. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.
Oudshoorn D; Rijs K; Limpens RWAL; Groen K; Koster AJ; Snijder EJ; Kikkert M; Bárcena M
mBio; 2017 Nov; 8(6):. PubMed ID: 29162711
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.
Burkard C; Verheije MH; Wicht O; van Kasteren SI; van Kuppeveld FJ; Haagmans BL; Pelkmans L; Rottier PJ; Bosch BJ; de Haan CA
PLoS Pathog; 2014 Nov; 10(11):e1004502. PubMed ID: 25375324
[TBL] [Abstract][Full Text] [Related]
19. Evaluating MERS-CoV Entry Pathways.
Qing E; Hantak MP; Galpalli GG; Gallagher T
Methods Mol Biol; 2020; 2099():9-20. PubMed ID: 31883084
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
Nakagawa K; Narayanan K; Wada M; Makino S
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
